Genetic spectrum of cardiomyopathies with neuromuscular phenotype

Frontiers in Bioscience - Scholar

Volumn 5 S, Issue 1, 2013, Pages 325-340

  Kostareva, Anna ^a,b   Sejersen, Thomas ^b   Sjoberg, Gunnar ^b  

^a ALMAZOV NATIONAL MEDICAL RESEARCH CENTRE   (Russian Federation)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cardiomyopathy; Genetics; Muscular dystrophy; Review

Indexed keywords

ALPHA ACTININ 2; ALPHA TROPOMYOSIN; CALRETICULIN; CARDIAC MYOSIN; CAVEOLIN; CAVEOLIN 3; CONNECTIN; DELTA SARCOGLYCAN; DESMIN; DYSTROPHIN; EMERIN; FHL1 PROTEIN; FUKUTIN; FUKUTIN RELATED PROTEIN; LAMIN A; LAMIN C; LIM PROTEIN; MYOMESIN; MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; NEBULIN; OBSCURIN; PHOSPHOLAMBAN; PRESENILIN 1; PRESENILIN 2; PROTEIN; SODIUM CHANNEL; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG;

ARRHYTHMOGENESIS; ARTICLE; BARTH SYNDROME; BECKER MUSCULAR DYSTROPHY; CARDIOMYOPATHY; CONGESTIVE CARDIOMYOPATHY; DANON DISEASE; DISTAL MYOPATHY; DUCHENNE MUSCULAR DYSTROPHY; DYSTROPHINOPATHY; EMERY DREIFUSS MUSCULAR DYSTROPHY; ENDOCARDIAL FIBROELASTOSIS; FABRY DISEASE; FAMILIAL PARTIAL LIPODYSTROPHY; FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY; HEART ARRHYTHMIA; HEMOCHROMATOSIS; HUMAN; LAMINOPATHY; LIGHT CHAIN; LIMB GIRDLE MUSCULAR DYSTROPHY; LONG QT SYNDROME; MUSCLE EYE BRAIN DISEASE; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY; MYOTONIC DYSTROPHY; NEMALINE MYOPATHY; NEUROMUSCULAR DISEASE; PHENOTYPE; RESPIRATORY FAILURE; SARCOGLYCANOPATHY; SUDDEN INFANT DEATH SYNDROME; VENTRICULAR NONCOMPACTION; WALKER WARBURG SYNDROME; X CHROMOSOME LINKED DISORDER; ANIMAL; GENETICS; PATHOLOGY; REVIEW;

ANIMALS; CARDIOMYOPATHIES; HUMANS; NEUROMUSCULAR DISEASES; PHENOTYPE;

EID: 84883723377     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/s375     Document Type: Article

References (113)

1. P Elliott, B Andersson, E Arbustini, Z Bilinska, F Cecchi, P Charron, O Dubourg, U Kuhl, B Maisch, WJ McKenna, L Monserrat, S Pankuweit, C Rapezzi, P Seferovic, L Tavazzi and A Keren: Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29, 270-276 (2008)
2. BJ Maron, JA Towbin, G Thiene, C Antzelevitch, D Corrado, D Arnett, AJ Moss, CE Seidman and JB Young: Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113, 1807-1816 (2006)
3. P Charron, M Arad, E Arbustini, C Basso, Z Bilinska, P Elliott, T Helio, A Keren, WJ McKenna, L Monserrat, S Pankuweit, A Perrot, C Rapezzi, A Ristic, H Seggewiss, I van Langen and L Tavazzi: Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 31, 2715-2726 (2010)
4. SJ Fowler, C Napolitano and SG Priori: The genetics of cardiomyopathy: genotyping and genetic counseling. Curr Treat Options Cardiovasc Med 11, 433-446 (2009)
5. RE Hershberger, J Lindenfeld, L Mestroni, CE Seidman, MR Taylor and JA Towbin: Genetic evaluation of cardiomyopathy-A Heart Failure Society of America practice guideline. J Card Fail 15, 83-97 (2009)
6. JA Towbin, JF Hejtmancik, P Brink, B Gelb, XM Zhu, JS Chamberlain, ER McCabe and M Swift: X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 87, 1854-1865 (1993)
7. F Muntoni, M Cau, A Ganau, R Congiu, G Arvedi, A Mateddu, MG Marrosu, C Cianchetti, G Realdi, A Cao and et al.: Brief report: deletion of the dystrophin musclepromoter region associated with X-linked dilated cardiomyopathy. N Engl J Med 329, 921-925 (1993)
8. T Dechat, SA Adam, P Taimen, T Shimi and RD Goldman: Nuclear lamins. Cold Spring Harb Perspect Biol 2, a000547 (2010)
9. D Frank, C Kuhn, HA Katus and N Frey: Role of the sarcomeric Z-disc in the pathogenesis of cardiomyopathy. Future Cardiol 3, 611-622 (2007)
10. Q Zhou, PH Chu, C Huang, CF Cheng, ME Martone, G Knoll, GD Shelton, S Evans and J Chen: Ablation of Cypher, a PDZ-LIM domain Z-line protein, causes a severe form of congenital myopathy. J Cell Biol 155, 605-612 (2001)
11. N Frey, T Barrientos, JM Shelton, D Frank, H Rutten, D Gehring, C Kuhn, M Lutz, B Rothermel, R Bassel-Duby, JA Richardson, HA Katus, JA Hill and EN Olson: Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress. Nat Med 10, 1336-1343 (2004)
12. K van Spaendonck-Zwarts, L van Hessem, JD Jongbloed, HE de Walle, Y Capetanaki, AJ van der Kooi, IM van Langen, MP van den Berg and JP van Tintelen: Desmin-related myopathy: a review and metaanalysis. Clin Genet (2010)
13. J Rankin and S Ellard: The laminopathies: a clinical review. Clin Genet 70, 261-274 (2006)
14. EM McNally: New approaches in the therapy of cardiomyopathy in muscular dystrophy. Annu Rev Med 58, 75-88 (2007)
15. J Finsterer and C Stollberger: Cardiac involvement in primary myopathies. Cardiology 94, 1-11 (2000)
16. J Finsterer and C Stollberger: Primary myopathies and the heart. Scand Cardiovasc J 42, 9-24 (2008)
17. A Romfh and EM McNally: Cardiac assessment in duchenne and becker muscular dystrophies. Curr Heart Fail Rep 7, 212-218 (2010)
18. MC Hermans, YM Pinto, IS Merkies, CE de Die-Smulders, HJ Crijns and CG Faber: Hereditary muscular dystrophies and the heart. Neuromuscul Disord 20, 479-492 (2010)
19. JC Kaplan: The 2011 version of the gene table of neuromuscular disorders. Neuromuscul Disord 20, 852-873 (2010)
20. E Manole: The dystrophin gene and its product-A view. Rom J Neurol Psychiatry 33, 109-119 (1995)
21. JL Mandel: Dystrophin. The gene and its product. Nature 339, 584-586 (1989)
22. F Muntoni, S Torelli and A Ferlini: Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2, 731-740 (2003)
23. J Feng, JY Yan, CH Buzin, SS Sommer and JA Towbin: Comprehensive mutation scanning of the dystrophin gene in patients with nonsyndromic X-linked dilated cardiomyopathy. J Am Coll Cardiol 40, 1120-1124 (2002)
24. E Arbustini, M Diegoli, P Morbini, B Dal Bello, N Banchieri, A Pilotto, F Magani, M Grasso, J Narula, A Gavazzi, M Vigano and L Tavazzi: Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy. J Am Coll Cardiol 35, 1760-1768 (2000)
25. N Cohen and F Muntoni: Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy. Heart 90, 835-841 (2004)
26. D Obler, BL Wu, V Lip, E Estrella, S Keck, C Haggan, M Semigran and LB Smoot: Familial dilated cardiomyopathy secondary to dystrophin splice site mutation. J Card Fail 16, 194-199 (2010)
27. M Shimizu, H Ino, T Yasuda, N Fujino, K Uchiyama, T Mabuchi, T Konno, T Kaneda, T Fujita, E Masuta, M Katoh, A Funada and H Mabuchi: Gene mutations in adult Japanese patients with dilated cardiomyopathy. Circ J 69, 150-153 (2005)
28. S Abbs, S Tuffery-Giraud, E Bakker, A Ferlini, T Sejersen and CR Mueller: Best practice guidelines on molecular diagnostics in Duchenne/Becker muscular dystrophies. Neuromuscul Disord 20, 422-427 (2010)
29. HJ Worman, LG Fong, A Muchir and SG Young: Laminopathies and the long strange trip from basic cell biology to therapy. J Clin Invest 119, 1825-1836 (2009)
30. HJ Worman, C Ostlund and Y Wang: Diseases of the nuclear envelope. Cold Spring Harb Perspect Biol 2, a000760 (2010)
31. M Zaremba-Czogalla, M Dubinska-Magiera and R Rzepecki: Laminopathies: the molecular background of the disease and the prospects for its treatment. Cell Mol Biol Lett 16, 114-148 (2011)
32. G Bonne, E Mercuri, A Muchir, A Urtizberea, HM Becane, D Recan, L Merlini, M Wehnert, R Boor, U Reuner, M Vorgerd, EM Wicklein, B Eymard, D Duboc, I Penisson-Besnier, JM Cuisset, X Ferrer, I Desguerre, D Lacombe, K Bushby, C Pollitt, D Toniolo, M Fardeau, K Schwartz and F Muntoni: Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann Neurol 48, 170-180 (2000)
33. D Araujo-Vilar, J Lado-Abeal, F Palos-Paz, G Lattanzi, MA Bandin, D Bellido, L Dominguez-Gerpe, C Calvo, O Perez, A Ramazanova, N Martinez-Sanchez, B Victoria and AT Costa-Freitas: A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy. Clin Endocrinol (Oxf) 69, 61-68 (2008)
34. E Mercuri, SC Brown, P Nihoyannopoulos, J Poulton, M Kinali, P Richard, RJ Piercy, S Messina, C Sewry, MM Burke, W McKenna, G Bonne and F Muntoni: Extreme variability of skeletal and cardiac muscle involvement in patients with mutations in exon 11 of the lamin A/C gene. Muscle Nerve 31, 602-609 (2005)
35. JH van Berlo, WG de Voogt, AJ van der Kooi, JP van Tintelen, G Bonne, RB Yaou, D Duboc, T Rossenbacker, H Heidbuchel, M de Visser, HJ Crijns and YM Pinto: Metaanalysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? J Mol Med 83, 79-83 (2005)
36. JP van Tintelen, RM Hofstra, H Katerberg, T Rossenbacker, AC Wiesfeld, GJ du Marchie Sarvaas, AA Wilde, IM van Langen, EA Nannenberg, AJ van der Kooi, M Kraak, IC van Gelder, DJ van Veldhuisen, Y Vos and MP van den Berg: High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics. Am Heart J 154, 1130-1139 (2007)
37. RF Marsman, A Bardai, AV Postma, JC Res, TT Koopmann, L Beekman, AC van der Wal, YM Pinto, RH Lekanne Deprez, AA Wilde, LJ Jordaens and CR Bezzina: A Complex Double Deletion in LMNA Underlies Progressive Cardiac Conduction Disease, Atrial Arrhythmias and Sudden Death. Circ Cardiovasc Genet (2011)
38. JP van Tintelen, RA Tio, WS Kerstjens-Frederikse, JH van Berlo, LG Boven, AJ Suurmeijer, SJ White, JT den Dunnen, GJ te Meerman, YJ Vos, AH van der Hout, J Osinga, MP van den Berg, DJ van Veldhuisen, CH Buys, RM Hofstra and YM Pinto: Severe myocardial fibrosis caused by a deletion of the 5' end of the lamin A/C gene. J Am Coll Cardiol 49, 2430-2439 (2007)
39. E Hookana, MJ Junttila, T Sarkioja, R Sormunen, M Niemela, MJ Raatikainen, P Uusimaa, E Lizotte, K Peuhkurinen, R Brugada and HV Huikuri: Cardiac arrest and left ventricular fibrosis in a Finnish family with the lamin A/C mutation. J Cardiovasc Electrophysiol 19, 743-747 (2008)
40. SB Parks, JD Kushner, D Nauman, D Burgess, S Ludwigsen, A Peterson, D Li, P Jakobs, M Litt, CB Porter, PS Rahko and RE Hershberger: Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy. Am Heart J 156, 161-169 (2008)
41. E Arbustini, A Pilotto, A Repetto, M Grasso, A Negri, M Diegoli, C Campana, L Scelsi, E Baldini, A Gavazzi and L Tavazzi: Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. J Am Coll Cardiol 39, 981-990 (2002)
42. Y Capetanaki, RJ Bloch, A Kouloumenta, M Mavroidis and S Psarras: Muscle intermediate filaments and their links to membranes and membranous organelles. Exp Cell Res 313, 2063-2076 (2007)
43. H Herrmann, SV Strelkov, P Burkhard and U Aebi: Intermediate filaments: primary determinants of cell architecture and plasticity. J Clin Invest 119, 1772-1783 (2009)
44. E Lazarides, BL Granger, DL Gard, CM O'Connor, J Breckler, M Price and SI Danto: Desmin-And vimentincontaining filaments and their role inthe assembly of the Z disk in muscle cells. Cold Spring Harb Symp Quant Biol 46 Pt 1, 351-378 (1982)
45. D Frank, C Kuhn, HA Katus and N Frey: The sarcomeric Z-disc: a nodal point in signalling and disease. J Mol Med 84, 446-468 (2006)
46. D Li, T Tapscoft, O Gonzalez, PE Burch, MA Quinones, WA Zoghbi, R Hill, LL Bachinski, DL Mann and R Roberts: Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 100, 461-464 (1999)
47. NE Bowles, KR Bowles and JA Towbin: The "final common pathway" hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy. Herz 25, 168-175 (2000)
48. G Pinol-Ripoll, A Shatunov, A Cabello, P Larrode, I de la Puerta, J Pelegrin, FJ Ramos, M Olive and LG Goldfarb: Severe infantile-onset cardiomyopathy associated with a homozygous deletion in desmin. Neuromuscul Disord 19, 418-422 (2009)
49. MR Taylor, D Slavov, L Ku, A Di Lenarda, G Sinagra, E Carniel, K Haubold, MM Boucek, D Ferguson, SL Graw, X Zhu, J Cavanaugh, CC Sucharov, CS Long, MR Bristow, P Lavori and L Mestroni: Prevalence of desmin mutations in dilated cardiomyopathy. Circulation 115, 1244-1251 (2007)
50. R Schroder, A Vrabie and HH Goebel: Primary desminopathies. J Cell Mol Med 11, 416-426 (2007)
51. JP van Tintelen, IC Van Gelder, A Asimaki, AJ Suurmeijer, AC Wiesfeld, JD Jongbloed, A van den Wijngaard, JB Kuks, KY van Spaendonck-Zwarts, N Notermans, L Boven, F van den Heuvel, HE Veenstra-Knol, JE Saffitz, RM Hofstra and MP van den Berg: Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene. Heart Rhythm 6, 1574-1583 (2009)
52. KY Park, MC Dalakas, HH Goebel, VJ Ferrans, C Semino-Mora, S Litvak, K Takeda and LG Goldfarb: Desmin splice variants causing cardiac and skeletal myopathy. J Med Genet 37, 851-857 (2000)
53. E Otten, A Asimaki, A Maass, IM van Langen, A van der Wal, N de Jonge, MP van den Berg, JE Saffitz, AA Wilde, JD Jongbloed and JP van Tintelen: Desmin mutations as a cause of right ventricular heart failure affect the intercalated disks. Heart Rhythm 7, 1058-1064 (2010)
54. B Klauke, S Kossmann, A Gaertner, K Brand, I Stork, A Brodehl, M Dieding, V Walhorn, D Anselmetti, D Gerdes, B Bohms, U Schulz, E Zu Knyphausen, M Vorgerd, J Gummert and H Milting: De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy. Hum Mol Genet 19, 4595-4607 (2010)
55. H Herrmann, H Bar, L Kreplak, SV Strelkov and U Aebi: Intermediate filaments: from cell architecture to nanomechanics. Nat Rev Mol Cell Biol 8, 562-573 (2007)
56. H Bar, N Mucke, A Kostareva, G Sjoberg, U Aebi and H Herrmann: Severe muscle disease-causing desmin mutations interfere with in vitro filament assembly at distinct stages. Proc Natl Acad Sci U S A 102, 15099-15104 (2005)
57. H Bar, A Kostareva, G Sjoberg, T Sejersen, HA Katus and H Herrmann: Forced expression of desmin and desmin mutants in cultured cells: impact of myopathic missense mutations in the central coiled-coil domain on network formation. Exp Cell Res 312, 1554-1565 (2006)
58. L Carlsson, C Fischer, G Sjoberg, RM Robson, T Sejersen and LE Thornell: Cytoskeletal derangements in hereditary myopathy with a desmin L345P mutation. Acta Neuropathol (Berl) 104, 493-504 (2002)
59. R Schroder and B Schoser: Myofibrillar myopathies: a clinical and myopathological guide. Brain Pathol 19, 483-492 (2009)
60. A Ariza, J Coll, MT Fernandez-Figueras, MD Lopez, JL Mate, O Garcia, A Fernandez-Vasalo and JJ Navas-Palacios: Desmin myopathy: a multisystem disorder involving skeletal, cardiac, and smooth muscle. Hum Pathol 26, 1032-1037 (1995)
61. P Vicart, A Caron, P Guicheney, Z Li, MC Prevost, A Faure, D Chateau, F Chapon, F Tome, JM Dupret, D Paulin and M Fardeau: A missense mutation in the alphaBcrystallin chaperone gene causes a desmin-related myopathy. Nat Genet 20, 92-95 (1998)
62. N Inagaki, T Hayashi, T Arimura, Y Koga, M Takahashi, H Shibata, K Teraoka, T Chikamori, A Yamashina and A Kimura: Alpha B-crystallin mutation in dilated cardiomyopathy. Biochem Biophys Res Commun 342, 379-386 (2006)
63. U Schara and BG Schoser: Myotonic dystrophies type 1 and 2: a summary on current aspects. Semin Pediatr Neurol 13, 71-79 (2006)
64. C Turner and D Hilton-Jones: The myotonic dystrophies: diagnosis and management. J Neurol Neurosurg Psychiatry 81, 358-367 (2010)
65. AB Ekstrom, L Hakenas-Plate, L Samuelsson, M Tulinius and E Wentz: Autism spectrum conditions in myotonic dystrophy type 1: a study on 57 individuals with congenital and childhood forms. Am J Med Genet B Neuropsychiatr Genet 147B, 918-926 (2008)
66. JW Day and LP Ranum: RNA pathogenesis of the myotonic dystrophies. Neuromuscul Disord 15, 5-16 (2005)
67. JW Day, K Ricker, JF Jacobsen, LJ Rasmussen, KA Dick, W Kress, C Schneider, MC Koch, GJ Beilman, AR Harrison, JC Dalton and LP Ranum: Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 60, 657-664 (2003)
68. JE Lee and TA Cooper: Pathogenic mechanisms of myotonic dystrophy. Biochem Soc Trans 37, 1281-1286 (2009)
69. S Rudnik-Schoneborn, M Schaupp, A Lindner, W Kress, E Schulze-Bahr, S Zumhagen, M Elbracht and K Zerres: Brugada-like cardiac disease in myotonic dystrophy type 2: report of two unrelated patients. Eur J Neurol (2010)
70. G Bassez, A Lazarus, I Desguerre, J Varin, P Laforet, HM Becane, C Meune, MC Arne-Bes, Z Ounnoughene, H Radvanyi, B Eymard and D Duboc: Severe cardiac arrhythmias in young patients with myotonic dystrophy type 1. Neurology 63, 1939-1941 (2004)
71. M Parisi, M Galderisi, M Sidiropulos, C Fiorillo, R Lanzillo, A D'Errico, M Grieco, P Innelli, L Santoro and O de Divitiis: Early detection of biventricular involvement in myotonic dystrophy by tissue Doppler. Int J Cardiol 118, 227-232 (2007)
72. WJ Groh, MR Groh, C Saha, JC Kincaid, Z Simmons, E Ciafaloni, R Pourmand, RF Otten, D Bhakta, GV Nair, MM Marashdeh, DP Zipes and RM Pascuzzi: Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med 358, 2688-2697 (2008)
73. R Breton and J Mathieu: Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy. Can J Cardiol 25, e23-27 (2009)
74. S Morner, P Lindqvist, C Mellberg, BO Olofsson, C Backman, M Henein, D Lundblad and H Forsberg: Profound cardiac conduction delay predicts mortality in myotonic dystrophy type 1. J Intern Med 268, 59-65 (2010)
75. M Poppe, L Cree, J Bourke, M Eagle, LV Anderson, D Birchall, M Brockington, M Buddles, M Busby, F Muntoni, A Wills and K Bushby: The phenotype of limb-girdle muscular dystrophy type 2I. Neurology 60, 1246-1251 (2003)
76. CA Boito, P Melacini, A Vianello, P Prandini, BF Gavassini, A Bagattin, G Siciliano, C Angelini and E Pegoraro: Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I. Arch Neurol 62, 1894-1899 (2005)
77. MC Walter, JA Petersen, R Stucka, D Fischer, R Schroder, M Vorgerd, A Schroers, H Schreiber, CO Hanemann, U Knirsch, A Rosenbohm, A Huebner, N Barisic, R Horvath, S Komoly, P Reilich, W Muller-Felber, D Pongratz, JS Muller, EA Auerswald and H Lochmuller: FKRP (826C>A) frequently causes limb-girdle muscular dystrophy in German patients. J Med Genet 41, e50 (2004)
78. M Poppe, J Bourke, M Eagle, P Frosk, K Wrogemann, C Greenberg, F Muntoni, T Voit, V Straub, D Hilton-Jones, C Shirodaria and K Bushby: Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I. Ann Neurol 56, 738-741 (2004)
79. T Arimura, YK Hayashi, T Murakami, Y Oya, S Funabe, E Arikawa-Hirasawa, N Hattori, I Nishino and A Kimura: Mutational analysis of fukutin gene in dilated cardiomyopathy and hypertrophic cardiomyopathy. Circ J 73, 158-161 (2009)
80. T Murakami, YK Hayashi, S Noguchi, M Ogawa, I Nonaka, Y Tanabe, M Ogino, F Takada, M Eriguchi, N Kotooka, KP Campbell, M Osawa and I Nishino: Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness. Ann Neurol 60, 597-602 (2006)
81. F Sheikh, A Raskin, PH Chu, S Lange, AA Domenighetti, M Zheng, X Liang, T Zhang, T Yajima, Y Gu, ND Dalton, SK Mahata, GW Dorn, 2nd, J Heller-Brown, KL Peterson, JH Omens, AD McCulloch and J Chen: An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice. J Clin Invest 118, 3870-3880 (2008)
82. S Brown, C Biben, LM Ooms, M Maimone, MJ McGrath, R Gurung, RP Harvey and CA Mitchell: The cardiac expression of striated muscle LIM protein 1 (SLIM1) is restricted to the outflow tract of the developing heart. J Mol Cell Cardiol 31, 837-843 (1999)
83. PH Chu, P Ruiz-Lozano, Q Zhou, C Cai and J Chen: Expression patterns of FHL/SLIM family members suggest important functional roles in skeletal muscle and cardiovascular system. Mech Dev 95, 259-265 (2000)
84. L Gueneau, AT Bertrand, JP Jais, MA Salih, T Stojkovic, M Wehnert, M Hoeltzenbein, S Spuler, S Saitoh, A Verschueren, C Tranchant, M Beuvin, E Lacene, NB Romero, S Heath, D Zelenika, T Voit, B Eymard, R Ben Yaou and G Bonne: Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy. Am J Hum Genet 85, 338-353 (2009)
85. BS Cowling, DL Cottle, BR Wilding, CE D'Arcy, CA Mitchell and MJ McGrath: Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features. Neuromuscul Disord 21, 237-251 (2011)
86. T Arimura, T Hayashi, Y Matsumoto, H Shibata, S Hiroi, T Nakamura, N Inagaki, K Hinohara, M Takahashi, SI Manatsu, T Sasaoka, T Izumi, G Bonne, K Schwartz and A Kimura: Structural analysis of four and half LIM protein-2 in dilated cardiomyopathy. Biochem Biophys Res Commun 357, 162-167 (2007)
87. S Tsubata, KR Bowles, M Vatta, C Zintz, J Titus, L Muhonen, NE Bowles and JA Towbin: Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest 106, 655-662 (2000)
88. N Sylvius, L Duboscq-Bidot, C Bouchier, P Charron, A Benaiche, P Sebillon, M Komajda and E Villard: Mutational analysis of the beta-And delta-sarcoglycan genes in a large number of patients with familial and sporadic dilated cardiomyopathy. Am J Med Genet A 120A, 8-12 (2003)
89. R Bauer, J Hudson, HD Muller, C Sommer, G Dekomien, J Bourke, D Routledge, K Bushby, J Klepper and V Straub: Does delta-sarcoglycan-Associated autosomal-dominant cardiomyopathy exist? Eur J Hum Genet 17, 1148-1153 (2009)
90. TM Williams and MP Lisanti: The Caveolin genes: from cell biology to medicine. Ann Med 36, 584-595 (2004)
91. T Hayashi, T Arimura, K Ueda, H Shibata, S Hohda, M Takahashi, H Hori, Y Koga, N Oka, T Imaizumi, M Yasunami and A Kimura: Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy. Biochem Biophys Res Commun 313, 178-184 (2004)
92. M Catteruccia, T Sanna, FM Santorelli, A Tessa, R Di Giacopo, D Sauchelli, A Verbo, M Lo Monaco and S Servidei: Rippling muscle disease and cardiomyopathy associated with a mutation in the CAV3 gene. Neuromuscul Disord 19, 779-783 (2009)
93. M Traverso, E Gazzerro, S Assereto, F Sotgia, R Biancheri, S Stringara, L Giberti, M Pedemonte, X Wang, S Scapolan, E Pasquini, MA Donati, F Zara, MP Lisanti, C Bruno and C Minetti: Caveolin-3 T78M and T78K missense mutations lead to different phenotypes in vivo and in vitro. Lab Invest 88, 275-283 (2008)
94. G Bonne, F Leturcq and R Ben Yaou. Emery-Dreifuss Muscular Dystrophy.Seattle (WA)(1993)
95. ML Karst, KJ Herron and TM Olson: X-linked nonsyndromic sinus node dysfunction and atrial fibrillation caused by emerin mutation. J Cardiovasc Electrophysiol 19, 510-515 (2008)
96. S Lange, F Xiang, A Yakovenko, A Vihola, P Hackman, E Rostkova, J Kristensen, B Brandmeier, G Franzen, B Hedberg, LG Gunnarsson, SM Hughes, S Marchand, T Sejersen, I Richard, L Edstrom, E Ehler, B Udd and M Gautel: The kinase domain of titin controls muscle gene expression and protein turnover. Science 308, 1599-1603 (2005)
97. V Carmignac, MA Salih, S Quijano-Roy, S Marchand, MM Al Rayess, MM Mukhtar, JA Urtizberea, S Labeit, P Guicheney, F Leturcq, M Gautel, M Fardeau, KP Campbell, I Richard, B Estournet and A Ferreiro: Cterminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy. Ann Neurol 61, 340-351 (2007)
98. M Satoh, M Takahashi, T Sakamoto, M Hiroe, F Marumo and A Kimura: Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. Biochem Biophys Res Commun 262, 411-417 (1999)
99. B Gerull, M Gramlich, J Atherton, M McNabb, K Trombitas, S Sasse-Klaassen, JG Seidman, C Seidman, H Granzier, S Labeit, M Frenneaux and L Thierfelder: Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet 30, 201-204 (2002)
100. M Itoh-Satoh, T Hayashi, H Nishi, Y Koga, T Arimura, T Koyanagi, M Takahashi, S Hohda, K Ueda, T Nouchi, M Hiroe, F Marumo, T Imaizumi, M Yasunami and A Kimura: Titin mutations as the molecular basis for dilated cardiomyopathy. Biochem Biophys Res Commun 291, 385-393 (2002)
101. M Tristani-Firouzi and SP Etheridge: Kir 2.1 channelopathies: the Andersen-Tawil syndrome. Pflugers Arch 460, 289-294 (2010)
102. M Vatta, B Mohapatra, S Jimenez, X Sanchez, G Faulkner, Z Perles, G Sinagra, JH Lin, TM Vu, Q Zhou, KR Bowles, A Di Lenarda, L Schimmenti, M Fox, MA Chrisco, RT Murphy, W McKenna, P Elliott, NE Bowles, J Chen, G Valle and JA Towbin: Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular noncompaction. J Am Coll Cardiol 42, 2014-2027 (2003)
103. E Purevjav, J Varela, M Morgado, DL Kearney, H Li, MD Taylor, T Arimura, CL Moncman, W McKenna, RT Murphy, S Labeit, M Vatta, NE Bowles, A Kimura, AM Boriek and JA Towbin: Nebulette mutations are associated with dilated cardiomyopathy and endocardial fibroelastosis. J Am Coll Cardiol 56, 1493-1502 (2010)
104. T Hayashi, T Arimura, M Itoh-Satoh, K Ueda, S Hohda, N Inagaki, M Takahashi, H Hori, M Yasunami, H Nishi, Y Koga, H Nakamura, M Matsuzaki, BY Choi, SW Bae, CW You, KH Han, JE Park, R Knoll, M Hoshijima, KR Chien and A Kimura: Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J Am Coll Cardiol 44, 2192-2201 (2004)
105. L Politano, V Nigro, L Passamano, V Petretta, LI Comi, S Papparella, G Nigro, PF Rambaldi, P Raia, A Pini, M Mora, MA Giugliano and MG Esposito: Evaluation of cardiac and respiratory involvement in sarcoglycanopathies. Neuromuscul Disord 11, 178-185 (2001)
106. H Tajsharghi, A Oldfors, DP Macleod and M Swash: Homozygous mutation in MYH7 in myosin storage myopathy and cardiomyopathy. Neurology 68, 962 (2007)
107. P Reilich, B Schoser, N Schramm, S Krause, J Schessl, W Kress, J Muller-Hocker, MC Walter and H Lochmuller: The p.G154S mutation of the alpha-B crystallin gene (CRYAB) causes late-onset distal myopathy. Neuromuscul Disord 20, 255-259 (2010)
108. A D'Amico, S Petrini, F Parisi, A Tessa, P Francalanci, G Grutter, FM Santorelli and E Bertini: Heart transplantation in a child with LGMD2I presenting as isolated dilated cardiomyopathy. Neuromuscul Disord 18, 153-155 (2008)
109. T Muller, M Krasnianski, R Witthaut, M Deschauer and S Zierz: Dilated cardiomyopathy may be an early sign of the C826A Fukutin-related protein mutation. Neuromuscul Disord 15, 372-376 (2005)
110. JT Kissel, EL Dimberg, AM Emslie-Smith, D Selcen and BM Keegan: A 49-year-old man with contractures, weakness, and cardiac arrhythmia. Neurology 72, 2036-2043 (2009)
111. H Knoblauch, C Geier, S Adams, B Budde, A Rudolph, U Zacharias, J Schulz-Menger, A Spuler, RB Yaou, P Nurnberg, T Voit, G Bonne and S Spuler: Contractures and hypertrophic cardiomyopathy in a novel FHL1 mutation. Ann Neurol 67, 136-140 (2010)
112. CH Wang, CG Bonnemann, A Rutkowski, T Sejersen, J Bellini, V Battista, JM Florence, U Schara, PM Schuler, K Wahbi, A Aloysius, RO Bash, C Beroud, E Bertini, K Bushby, RD Cohn, AM Connolly, N Deconinck, I Desguerre, M Eagle, B Estournet-Mathiaud, A Ferreiro, A Fujak, N Goemans, ST Iannaccone, P Jouinot, M Main, P Melacini, W Mueller-Felber, F Muntoni, LL Nelson, J Rahbek, S Quijano-Roy, C Sewry, K Storhaug, A Simonds, B Tseng, J Vajsar, A Vianello and R Zeller: Consensus statement on standard of care for congenital muscular dystrophies. J Child Neurol 25, 1559-1581 (2010)
113. N Carboni, G Marrosu, M Porcu, A Mateddu, E Solla, E Cocco, MA Maioli, V Oppo, R Piras and MG Marrosu: Dilated cardiomyopathy with conduction defects in a patient with partial merosin deficiency due to mutations in the laminin-Alpha2-chain gene: a chance association or a novel phenotype? Muscle Nerve 44, 826-828 (2011)